Targeting Pan-Tumor Associated Antigen B7H3 via Tri-specific Killer Engager Therapy Enhances Specificity and Function Against a Broad Range of Solid Tumors

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.